Ginsenoside Rh2 decrease the expression levels of ABCB1 when co-treated with oxaliplatin in colon cancer cells which is potential to reverse chemoresistance of oxaliplatin 60. This evidence concerns the gene ABCB1 and colonic neoplasm.